Telomir Pharmaceuticals, Inc. (TELO) earnings
TELO earnings moved a median of -2.40% by the close. Quarterly and annual TELO reports and results, each read against the price at its own news timestamp. Back to the TELO overview →
12 measured TELO earnings events.
Where these TELO earnings landedvs 12 measured TELO earnings reactions
| Middle 50% of TELO earnings reactions | -4.31% to +0.98% |
|---|---|
| Median reaction (to close) | -2.40% |
| Measured reactions | 12 |
Point-in-time · zero look-ahead
Half of the 12 TELO earnings events with a measured close landed between -4.31% and +0.98%; 33% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Telomir Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -2.82% | |
| Form 10-Q Telomir Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | +0.68% | +2.83% | |
| Form 10-Q Telomir Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | — | -0.39% | |
| Form 10-K Telomir Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +0.76% | -3.79% | |
| Form 10-Q Telomir Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | -1.45% | +5.97% | |
| Form 10-Q Telomir Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | +0.40% | -1.97% | |
| Form 10-Q Telomir Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | +2.62% | -11.61% | |
| Form 10-K Telomir Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +0.00% | +3.33% | |
| Form 10-Q Telomir Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | -0.24% | -2.93% | |
| Form 10-Q Telomir Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | -5.88% | -10.35% | |
| Form 10-Q Telomir Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | — | -5.90% | |
| Form 10-K Telomir Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +0.37% | +0.37% |
Keep exploring
More TELO: analyst actions → · SEC filings → · TELO overview →